Description:
 
 Opioids are largely used in cancer pain management and end-stage diseases in which palliative care is required. However, these can be addictive due to their analgesic nature. Opioids are the most prescribed medications for the treatment of both acute and chronic pain. Originally used to treat cancer-related pain, their use has expanded over the past 10 to 15 years to the treatment of chronic non-cancer pain. The US Food and Drug Administration (FDA) has emphasized the importance of developing abuse deterrent formulations of opioids. Many pharmaceutical companies are working to address the problem of opioid abuse and to assure that such medications remain available for use in appropriate patients.
 The market is analyzed across four geographical regions, namely, North America (U.S., Canada and
 Mexico), Europe (UK, Germany, France and rest of Europe), Asia-Pacific (China, Japan, India and rest of
 Asia-Pacific), and LAMEA (Latin America, Middle East and Africa). North America holds the highest
 market about 75% of total market share. Whereas Asia Pacific is the fastest growing region with the
 CAGR of 4.33%. The US consumes 80% of the world's legal and illegal opioids; they are the country's
 most abused prescription drug.
 The opioid market is segmented on the basis of by application, by Type and by region. There are two
 types of application that we have considered viz. pain relief and anesthesia. Pain relief segment hold
 the largest share of about 75.8 % and is the fastest growing with the CAGR of 3.60 % in the forecasted
 period. Opioids for pain relief include naturally occurring morphine and synthetic drugs such as
 oxycodone, hydrocodone, codeine, and fentanyl.
 The global opioid market by type is segmented as Oxycodone, Hydromorphone, Codeine, and Fentanyl of which Oxycodone segment holds the largest market share in 2017 of around 38%. Hydromorphone is projected to grow at a highest CAGR of 3.98% in the forecasted period There are various regulatory bodies actively looking after company rules & regulations for addressing
 Association which includes USFDA (United States Food and Drug Administration), Medicines and
 Healthcare Products Regulatory Agency (MHRA), Therapeutic Goods Administration (TGA) are the few regulatory agencies and organizations established in respective countries. World Health Organization (WHO), Pan American Health Organization (PAHO), World Trade Organization (WTO), International Conference on Harmonization (ICH), World Intellectual Property Organization (WIPO) are some of the international regulatory agencies and organizations
 Key companies profiled in the report are Johnson & Johnson (U.S), Teva Pharmaceutical (Israel),
 Purdue Pharma (U.S.), Mylan (U.S.), INSYS INSYS Therapeutics (U.S.), Depomed (U.S.), Endo (U.S.),
 Pfizer (U.S.), Hikma (U.K.), Mallinckrodt (U.K.).
Table of Content
1 Introduction
2 Executive Summary
3. Market Outlook
4 Opioids Drug Type Analysis
5 Opioids Drug Application Analysis
6 Global Opioids Drug Regional Analysis
Key Market Players
J&J
 Teva
 Purdue Pharma
 Mylan
 INSYS
 Depomed
 Endo
 Pfizer
 Hikma
 Mallinckrodt
Contact us
 Email: [email protected]
 Website: https://globalresearchview.com/subscription/